Recruiting Diabetic Retinopathy Studies in Glendale
Fenofibrate for Prevention of DR Worsening
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...
About Diabetic Retinopathy Clinical Trials in Glendale
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 2 diabetic retinopathy clinical trials recruiting participants in Glendale, ARIZONA. These studies are seeking a combined 738 participants. Research is being sponsored by Jaeb Center for Health Research, Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Glendale — FAQ
Are there diabetic retinopathy clinical trials in Glendale?
Yes, there are 2 diabetic retinopathy clinical trials currently recruiting in Glendale, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Glendale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you about next steps.
Are clinical trials in Glendale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glendale studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 2 active trials in Glendale are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated March 2, 2026 from ClinicalTrials.gov